TY - JOUR
T1 - Unintended positive and negative effects of drugs on lipoproteins.
AU - Siahmansur, Tarza J
AU - Schofield, Jonathan D
AU - Azmi, Shazli
AU - Liu, Yifen
AU - Durrington, Paul N
AU - Soran, Handrean
PY - 2015/6/22
Y1 - 2015/6/22
N2 - PURPOSE OF REVIEW: Dyslipidaemia is an important cardiovascular disease risk factor. Many drugs affect lipid profile and lipoprotein metabolism. We reviewed unintended effects of nonlipid modifying, commonly used medications on lipid profile and lipoprotein metabolism. RECENT FINDING: Several detrimental effects of many drug classes such as diuretics, antidepressant, anticonvulsant and antiretroviral drugs have been reported, whereas other drug classes such as antiobesity, alpha 1-blockers, oestrogens and thyroid replacement therapy were associated with positive effects. SUMMARY: Dyslipidaemia is a common side-effect of many medications. This should be taken into consideration, especially in patients at high risk of cardiovascular disease. Other drugs demonstrated positive effects on circulating lipids and lipoproteins. The impact of these unintended effects on atherosclerotic disease risk and progression is unclear.
AB - PURPOSE OF REVIEW: Dyslipidaemia is an important cardiovascular disease risk factor. Many drugs affect lipid profile and lipoprotein metabolism. We reviewed unintended effects of nonlipid modifying, commonly used medications on lipid profile and lipoprotein metabolism. RECENT FINDING: Several detrimental effects of many drug classes such as diuretics, antidepressant, anticonvulsant and antiretroviral drugs have been reported, whereas other drug classes such as antiobesity, alpha 1-blockers, oestrogens and thyroid replacement therapy were associated with positive effects. SUMMARY: Dyslipidaemia is a common side-effect of many medications. This should be taken into consideration, especially in patients at high risk of cardiovascular disease. Other drugs demonstrated positive effects on circulating lipids and lipoproteins. The impact of these unintended effects on atherosclerotic disease risk and progression is unclear.
U2 - 10.1097/MOL.0000000000000198
DO - 10.1097/MOL.0000000000000198
M3 - Article
C2 - 26103613
SN - 1473-6535
JO - Current opinion in lipidology
JF - Current opinion in lipidology
ER -